• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿失禁患者满意度的全球评分及对治疗改善的认知:三种全球患者评分的验证

Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings.

作者信息

Burgio Kathryn L, Goode Patricia S, Richter Holly E, Locher Julie L, Roth David L

机构信息

Birmingham/Atlanta Geriatric Research, Education, and Clinical Center, Department of Veterans Affairs Medical Center, Birmingham, Alabama 35233, USA.

出版信息

Neurourol Urodyn. 2006;25(5):411-7. doi: 10.1002/nau.20243.

DOI:10.1002/nau.20243
PMID:16652380
Abstract

AIMS

To test the validity of three patient global ratings, satisfaction, perception of improvement, and estimated percent improvement, for measuring outcomes of behavioral treatment for urinary incontinence.

METHODS

This report is a secondary analysis of data from three randomized controlled trials testing behavioral interventions for incontinence. Participants were 359 community-dwelling women, aged 40-92 years, with stress, urge, or mixed urinary incontinence. All participants received an 8-week program of clinic-based or self-administered behavioral training. Subjective outcomes included a patient satisfaction question (PSQ), global perception of improvement (GPI), and estimated percent improvement (EPI). Convergent validity was tested by examining the relationship between each measure and reduction of incontinence (bladder diary), change on the incontinence impact questionnaire (IIQ), and desire for another treatment. Discriminant validity was explored by examining the relationship of the global ratings to five measures not expected to be related to outcome (age, race, BMI, education level, and change in perceived pain).

RESULTS

All three patient global ratings were significantly associated with each other (P < 0.0001), with diary measures of reduction of incontinence episodes (P < 0.0001), and change in the IIQ (P < 0.005), and inversely associated with desire for another treatment (P < 0.0001). All three patient ratings were not significantly associated with age, race, BMI, education level, or change in perceived pain.

CONCLUSION

Patient global ratings of satisfaction, perception of improvement, and estimated percent improvement have acceptable convergent and discriminant validity for measuring outcomes in studies of behavioral treatment for urinary incontinence.

摘要

目的

检验三种患者总体评分(满意度、改善感知和估计改善百分比)在测量尿失禁行为治疗效果方面的有效性。

方法

本报告是对三项测试尿失禁行为干预的随机对照试验数据的二次分析。参与者为359名年龄在40 - 92岁之间、患有压力性、急迫性或混合性尿失禁的社区居住女性。所有参与者都接受了为期8周的基于诊所或自我管理的行为训练项目。主观结果包括患者满意度问题(PSQ)、总体改善感知(GPI)和估计改善百分比(EPI)。通过检查每种测量方法与尿失禁减少情况(膀胱日记)、尿失禁影响问卷(IIQ)的变化以及再次治疗意愿之间的关系来测试收敛效度。通过检查总体评分与五项预期与结果无关的测量指标(年龄、种族、体重指数、教育水平和感知疼痛变化)之间的关系来探索区分效度。

结果

所有三项患者总体评分彼此之间均显著相关(P < 0.0001),与尿失禁发作减少的日记测量指标显著相关(P < 0.0001),与IIQ的变化显著相关(P < 0.005),并且与再次治疗意愿呈负相关(P < 0.0001)。所有三项患者评分与年龄、种族、体重指数、教育水平或感知疼痛变化均无显著关联。

结论

患者对满意度、改善感知和估计改善百分比的总体评分在测量尿失禁行为治疗研究的结果方面具有可接受的收敛效度和区分效度。

相似文献

1
Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings.尿失禁患者满意度的全球评分及对治疗改善的认知:三种全球患者评分的验证
Neurourol Urodyn. 2006;25(5):411-7. doi: 10.1002/nau.20243.
2
Re: Burgio KL, Goode PS, Richter HE, et al. 2006. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings. Neurourol Urodynam 25:411-417.回复:布尔乔 KL、古德 PS、里希特 HE 等人。2006 年。尿失禁治疗患者满意度的全球评分及对改善的认知:三种全球患者评分的验证。《神经泌尿学与尿动力学》25:411 - 417。
Neurourol Urodyn. 2007;26(3):456. doi: 10.1002/nau.20294.
3
Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study.行为增强药物减少尿失禁(BE-DRI)研究的设计
Contemp Clin Trials. 2007 Jan;28(1):48-58. doi: 10.1016/j.cct.2006.06.002. Epub 2006 Jun 18.
4
Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).膀胱过度活动症治疗满意度问卷(OAB-SAT-q)的心理测量学验证
Neurourol Urodyn. 2009;28(5):416-22. doi: 10.1002/nau.20672.
5
Rating improvements in urinary incontinence: do patients and their physicians agree?尿失禁症状改善的评级:患者与医生的看法一致吗?
Age Ageing. 2008 Jul;37(4):379-83. doi: 10.1093/ageing/afn108.
6
"Unblinding" in randomized controlled drug trials for urinary incontinence: Implications for assessing outcomes when adverse effects are evident.尿失禁随机对照药物试验中的“揭盲”:不良反应明显时对评估结果的影响
Neurourol Urodyn. 2005;24(1):13-20. doi: 10.1002/nau.20083.
7
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.托特罗定缓释片对患有膀胱过度活动症和急迫性尿失禁的性活跃女性患者报告结局的影响。
Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.
8
Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.联合行为治疗和个体化药物治疗与单纯个体化药物治疗女性急迫性尿失禁的比较。
J Urol. 2010 Aug;184(2):598-603. doi: 10.1016/j.juro.2010.03.141. Epub 2010 Jun 19.
9
Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.膀胱过度活动症满意度(OAB-S)问卷的编制与验证
Neurourol Urodyn. 2008;27(3):179-90. doi: 10.1002/nau.20455.
10
Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence.用于尿失禁女性分诊的两项定量问卷的验证
Obstet Gynecol. 2005 Oct;106(4):767-73. doi: 10.1097/01.AOG.0000178168.33249.49.

引用本文的文献

1
The impact of age on stress urinary incontinence outcomes in patients who underwent trans-obturator tape procedures.年龄对接受经闭孔尿道中段悬吊带术患者压力性尿失禁治疗效果的影响。
Pak J Med Sci. 2025 Jun;41(6):1605-1611. doi: 10.12669/pjms.41.6.9793.
2
Long-Term Outcomes Associated with the Use of a Soft, Partially Absorbable Transobturator Mid-Urethral Tape for the Treatment of Stress Urinary Incontinence.使用柔软、部分可吸收的经闭孔尿道中段吊带治疗压力性尿失禁的长期疗效
J Clin Med. 2025 May 20;14(10):3572. doi: 10.3390/jcm14103572.
3
Intravaginal devices for running-induced urinary incontinence symptoms in females: a study protocol.
用于女性跑步引起的尿失禁症状的阴道内装置:一项研究方案。
BJU Int. 2025 Jun;135(6):931-939. doi: 10.1111/bju.16708. Epub 2025 Mar 12.
4
Telehealth exercise for continence after gynaecological cancer treatment (TELE-CONNECT): a protocol for a co-designed pragmatic randomised controlled trial.妇科癌症治疗后控尿的远程医疗锻炼(TELE-CONNECT):一项基于共识的实用随机对照试验方案。
BMC Womens Health. 2024 Sep 27;24(1):529. doi: 10.1186/s12905-024-03365-9.
5
Real-World Evidence From a Digital Health Treatment Program for Female Urinary Incontinence: Observational Study of Outcomes Following User-Centered Product Design.一项针对女性尿失禁的数字健康治疗项目的真实世界证据:以用户为中心的产品设计后的结果观察性研究。
JMIR Form Res. 2024 Jun 27;8:e58551. doi: 10.2196/58551.
6
Bladder training for treating overactive bladder in adults.膀胱训练治疗成人膀胱过度活动症。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD013571. doi: 10.1002/14651858.CD013571.pub2.
7
Optimizing remote access to urinary incontinence treatments for women veterans (PRACTICAL): Study protocol for a pragmatic clinical trial comparing two virtual care options.优化女性退伍军人尿失禁治疗的远程访问(实用):一项比较两种虚拟护理方案的实用临床试验研究方案。
Contemp Clin Trials. 2023 Oct;133:107328. doi: 10.1016/j.cct.2023.107328. Epub 2023 Sep 1.
8
Satisfaction and its determinants of rural upper gastrointestinal cancer screening in China: a preliminary cross-sectional study.中国农村上消化道癌筛查的满意度及其决定因素:一项初步的横断面研究。
BMJ Open. 2022 Sep 2;12(9):e061483. doi: 10.1136/bmjopen-2022-061483.
9
The effect of pelvic floor muscle training for women with pelvic organ prolapse: a meta-analysis.盆腔器官脱垂女性进行盆底肌训练的效果:一项荟萃分析。
Int Urogynecol J. 2022 Jul;33(7):1789-1801. doi: 10.1007/s00192-022-05139-z. Epub 2022 Mar 21.
10
Exploratory evaluation of baseline cognition as a predictor of perceived benefit in a study of behavioral therapy for urinary incontinence in Parkinson disease.探索性评估基线认知作为帕金森病患者行为治疗尿失禁研究中感知获益的预测指标。
Neurourol Urodyn. 2022 Mar;41(3):841-846. doi: 10.1002/nau.24891. Epub 2022 Feb 19.